RxDoctor Payments Data

Stacy Kelly, NP

Family · Pittsburgh, PANPI 1619514742

Payments from drug & device makers

$2,061in general payments, 2019–2025

Across 96 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$633
  • Astellas Pharma US Inc$461
  • Pfizer$382
  • Boston Scientific$151
  • Calyxo, Inc.$51
  • Ferring Pharmaceuticals Inc.$50
  • plus $332 from 11 others

What the payments were for

  • Food & beverage$1,79587%
  • Education$26613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,061 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$11,396
Medicare patients
79
Services billed
368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron290$230,404
Mirabegron ErMirabegron39$26,237
Tamsulosin Hcl1,154$20,740
Finasteride679$8,731
Testosterone33$7,795
NitrofurantoinNitrofurantoin Macrocrystal197$7,716
Methenamine Hippurate63$7,612
Dutasteride141$6,006
Trimethoprim56$5,475
Potassium Citrate ErPotassium Citrate33$4,757
Solifenacin Succinate127$4,733
Bicalutamide96$4,080
Bethanechol Chloride25$3,093
Trospium Chloride ErTrospium Chloride18$3,053
Fosfomycin Tromethamine26$2,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$461$230,404290 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,717 family providers in Pennsylvania.

Other family in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →